Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($3.06), $1.10 worse than the analyst estimate of ($1.96).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.